Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Jul;20(1):9–16. doi: 10.1111/j.1365-2125.1985.tb02792.x

Effect on postural sway of various benzodiazepine tranquillizers.

A Patat, P Foulhoux
PMCID: PMC1400619  PMID: 2862898

Abstract

The effects of various benzodiazepine tranquillizers (clobazam 20 mg, bromazepam 6 mg and lorazepam 2 mg) were investigated by posturography in 16 subjects in a controlled trial. Twelve received each of the three anxiolytics for 1 week in a cross-over design, four received placebo for 1 week during the three successive treatment periods. A pharmacodynamic study was carried out after the first administration, and another assessment was done after 1 week of treatment. The first administration of lorazepam caused the most marked disturbances of body sway (increase of spectral energies, length and amplitude of the stabilogram). The first administration of bromazepam was also accompanied by an increase of the posturographic parameters, although less marked. Administration of clobazam did not produce any impairment of equilibrium, indicating that it is devoid of any sedative effect measurable by posturography. No changes of the postural sway can be detected on the measurement recorded 10 h after the last dose of 1 week's treatment.

Full text

PDF
9

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aranko K., Mattila M. J., Seppälä T. Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man. Br J Clin Pharmacol. 1983 May;15(5):545–552. doi: 10.1111/j.1365-2125.1983.tb02088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barzaghi F., Fournex R., Mantegazza P. Pharmacological and toxicological properties of clobazam (1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine), a new psychotherapeutic agent. Arzneimittelforschung. 1973 May;23(5):683–686. [PubMed] [Google Scholar]
  3. Bell R. W., Dickie D. S., Stewart-Jones J., Turner P. Lorazepam on visuo-motor co-ordination and visual function in man. J Pharm Pharmacol. 1973 Jan;25(1):87–88. doi: 10.1111/j.2042-7158.1973.tb09126.x. [DOI] [PubMed] [Google Scholar]
  4. Bessineton J. C., Bizzo G., Pacifici M., Baron J. B. Statokinésigramme, taille, poids, sexe, reproductibilité. Agressologie. 1976;17(SPECNO):49–54. [PubMed] [Google Scholar]
  5. Borland R. G., Nicholson A. N. Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam. Br J Clin Pharmacol. 1975 Jun;2(3):215–221. doi: 10.1111/j.1365-2125.1975.tb01578.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dichgans J., Mauritz K. H., Allum J. H., Brandt T. Postural sway in normals and atactic patients: analysis of the stabilising and destabilizing effects of vision. Agressologie. 1976;17(100 Spec No):15–24. [PubMed] [Google Scholar]
  7. Diener H. C., Dichgans J., Bacher M., Gompf B. Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol. 1984 Feb;57(2):134–142. doi: 10.1016/0013-4694(84)90172-x. [DOI] [PubMed] [Google Scholar]
  8. File S. E., Bond A. J. Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology (Berl) 1979;66(3):309–313. doi: 10.1007/BF00428325. [DOI] [PubMed] [Google Scholar]
  9. Gantchev G., Baron J. B., Dounev S., Draganova N. Les oscillations du corps étudiées chez des sujets, yeux ouverts ou yeux fermś. C R Seances Soc Biol Fil. 1971;165(6):1237–1241. [PubMed] [Google Scholar]
  10. Greenblatt D. J., Shader R. I., Divoll M., Harmatz J. S. Benzodiazepines: a summary of pharmacokinetic properties. Br J Clin Pharmacol. 1981;11 (Suppl 1):11S–16S. doi: 10.1111/j.1365-2125.1981.tb01833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Greenblatt D. J., Shader R. I., Franke K., MacLaughlin D. S., Harmatz J. S., Allen M. D., Werner A., Woo E. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci. 1979 Jan;68(1):57–63. doi: 10.1002/jps.2600680119. [DOI] [PubMed] [Google Scholar]
  12. Hindmarch I. A preliminary study of the effects of prepeated doses of clobazam on aspects of performance, arousal and behaviour in a group of anxiety rated volunteers. Eur J Clin Pharmacol. 1979 Aug;16(1):17–21. doi: 10.1007/BF00644961. [DOI] [PubMed] [Google Scholar]
  13. Hindmarch I., Gudgeon A. C. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol. 1980 Aug;10(2):145–150. doi: 10.1111/j.1365-2125.1980.tb01731.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hindmarch I., Hanks G. W., Hewett A. J. Clobazam, a 1,5-benzodiazepine, and car-driving ability. Br J Clin Pharmacol. 1977 Oct;4(5):573–578. doi: 10.1111/j.1365-2125.1977.tb00788.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hindmarch I. Some aspects of the effects of clobazam on human psychomotor performance. Br J Clin Pharmacol. 1979;7 (Suppl 1):77S–82S. doi: 10.1111/j.1365-2125.1979.tb04669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hobi V., Dubach U. C., Skreta M., Forgo I., Riggenbach H. The subacute effect of bromazepam on psychomotor activity and subjective mood. J Int Med Res. 1982;10(3):140–146. doi: 10.1177/030006058201000302. [DOI] [PubMed] [Google Scholar]
  17. Kaplan S. A., Jack M. L., Weinfeld R. E., Glover W., Weissman L., Cotler S. Biopharmaceutical and clinical pharmacokinetic profile of bromazepam. J Pharmacokinet Biopharm. 1976 Feb;4(1):1–16. doi: 10.1007/BF01271440. [DOI] [PubMed] [Google Scholar]
  18. Kapteyn T. S., Bles W., Njiokiktjien C. J., Kodde L., Massen C. H., Mol J. M. Standardization in platform stabilometry being a part of posturography. Agressologie. 1983 Jun;24(7):321–326. [PubMed] [Google Scholar]
  19. Kapteyn T. S., de Wit G. Posturography as an auxiliary in vestibular investigation. Acta Otolaryngol. 1972 Feb-Mar;73(2):104–111. doi: 10.3109/00016487209138918. [DOI] [PubMed] [Google Scholar]
  20. Mauritz K. H., Dietz V. Characteristics of postural instability induced by ischemic blocking of leg afferents. Exp Brain Res. 1980;38(1):117–119. doi: 10.1007/BF00237939. [DOI] [PubMed] [Google Scholar]
  21. Njiokiktjien C., De Rijke W., Dieker-Van Ophem A., Voorhoeve-Coebergh O. A possible contribution of stabilography to the differential diagnosis of cerebellar processes. Agressologie. 1978;19(B):87–88. [PubMed] [Google Scholar]
  22. Rupp W., Badian M., Christ O., Hajdú P., Kulkarni R. D., Taeuber K., Uihlein M., Bender R., Vanderbeke O. Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol. 1979;7 (Suppl 1):51S–57S. doi: 10.1111/j.1365-2125.1979.tb04665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Saario I. Psychomotor skills during subacute treatment with thioridazine and bromazepam, and their combined effects with alcohol. Ann Clin Res. 1976 Apr;8(2):117–123. [PubMed] [Google Scholar]
  24. Salkind M. R., Hanks G. W., Silverstone J. T. Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice. Br J Clin Pharmacol. 1979;7 (Suppl 1):113S–118S. doi: 10.1111/j.1365-2125.1979.tb04676.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Seidel H., Bräuer D., Bastek R., Issel I. On the quantitative characterization of human body sway in experiments with long-term performance. Acta Biol Med Ger. 1978;37(10):1551–1561. [PubMed] [Google Scholar]
  26. Seppälä K., Korttila K., Häkkinen S., Linnoila M. Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam. Br J Clin Pharmacol. 1976 Oct;3(5):831–841. doi: 10.1111/j.1365-2125.1976.tb00635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Seppälä T., Aranko K., Mattila M. J., Shrotriya R. C. Effects of alcohol on buspirone and lorazepam actions. Clin Pharmacol Ther. 1982 Aug;32(2):201–207. doi: 10.1038/clpt.1982.148. [DOI] [PubMed] [Google Scholar]
  28. Taeuber K., Badian M., Brettel H. F., Royen T., Rupp W., Sittig W., Uihlein M. Kinetic and dynamic interaction of clobazam and alcohol. Br J Clin Pharmacol. 1979;7 (Suppl 1):91S–97S. doi: 10.1111/j.1365-2125.1979.tb04672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wittenborn J. R., Flaherty C. F., Jr, McGough W. E., Nash R. J. Psychomotor changes during initial day of benzodiazepine medication. Br J Clin Pharmacol. 1979;7 (Suppl 1):69S–76S. doi: 10.1111/j.1365-2125.1979.tb04668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES